Sweden · Delayed Price · Currency is SEK Dextech Medical AB Statistics
Total Valuation
XSAT:DEX has a market cap or net worth of SEK 185.78 million. The enterprise value is 175.66 million.
| Market Cap | 185.78M |
| Enterprise Value | 175.66M |
Important Dates
The last earnings date was Tuesday, May 5, 2026.
| Earnings Date | May 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
XSAT:DEX has 18.49 million shares outstanding. The number of shares has decreased by -1.00% in one year.
| Current Share Class | 18.49M |
| Shares Outstanding | 18.49M |
| Shares Change (YoY) | -1.00% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 44.75 |
| PB Ratio | 9.22 |
| P/TBV Ratio | 18.10 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -28.70 |
| EV / Sales | 42.31 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 20.18
| Current Ratio | 20.18 |
| Quick Ratio | 20.18 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -26.38% and return on invested capital (ROIC) is -17.09%.
| Return on Equity (ROE) | -26.38% |
| Return on Assets (ROA) | -16.79% |
| Return on Invested Capital (ROIC) | -17.09% |
| Return on Capital Employed (ROCE) | -31.49% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 4.15M |
| Profits Per Employee | -6.12M |
| Employee Count | 1 |
| Asset Turnover | 0.18 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +133.72% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +133.72% |
| 50-Day Moving Average | 10.25 |
| 200-Day Moving Average | 9.12 |
| Relative Strength Index (RSI) | 48.23 |
| Average Volume (20 Days) | 7,583 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, XSAT:DEX had revenue of SEK 4.15 million and -6.12 million in losses. Loss per share was -0.33.
| Revenue | 4.15M |
| Gross Profit | 4.10M |
| Operating Income | -6.34M |
| Pretax Income | -6.12M |
| Net Income | -6.12M |
| EBITDA | -5.70M |
| EBIT | -6.34M |
| Loss Per Share | -0.33 |
Balance Sheet
The company has 10.12 million in cash and n/a in debt, with a net cash position of 10.12 million or 0.55 per share.
| Cash & Cash Equivalents | 10.12M |
| Total Debt | n/a |
| Net Cash | 10.12M |
| Net Cash Per Share | 0.55 |
| Equity (Book Value) | 20.14M |
| Book Value Per Share | 1.09 |
| Working Capital | 10.26M |
Cash Flow
| Operating Cash Flow | -1.33M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 648,229 |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 98.70%, with operating and profit margins of -152.78% and -147.41%.
| Gross Margin | 98.70% |
| Operating Margin | -152.78% |
| Pretax Margin | -147.41% |
| Profit Margin | -147.41% |
| EBITDA Margin | -137.17% |
| EBIT Margin | -152.78% |
| FCF Margin | n/a |
Dividends & Yields
XSAT:DEX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.00% |
| Shareholder Yield | 1.00% |
| Earnings Yield | -3.29% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |